Correlation between topoisomerase-IIα gene amplification and protein expression in HER-2 amplified breast cancer

  • Authors:
    • V. Durbecq
    • C. Desmed
    • M. Paesmans
    • F. Cardoso
    • A. Di Leo
    • M. Mano
    • G. Rouas
    • J.-Y. Leroy
    • C. Sotiriou
    • M. Piccart
    • D. Larsimont
  • View Affiliations

  • Published online on: November 1, 2004     https://doi.org/10.3892/ijo.25.5.1473
  • Pages: 1473-1479
Metrics: Total Views: 0 (Spandidos Publications: | PMC Statistics: )
Total PDF Downloads: 0 (Spandidos Publications: | PMC Statistics: )


Abstract

Topoisomerase-IIα (topo-II) is a molecular target for topo-II inhibitors, which makes it a potential predictive marker of responsiveness to these agents. We aim to correlate topo-II gene and protein status on 103 HER-2 amplified breast cancer samples. Paraffin-embedded blocks were screened by FISH for topo-II gene amplification (topo-II: CEP17 ratio ≥1.5; triple probe by Vysis inc.) and analyzed by IHC for topo-II protein expression (continuous variable; clone KiS1) and Ki-67 (positive if >25% of stained cells; clone MIB-1). Topo-II gene amplification was observed in 36.9% (38/103) of the HER-2 amplified study population. HER-2 amplification level (e.g. copy number) was not shown to be predictive for topo-II amplification. The median percentage of topo-II positively stained cells by IHC for topo-II non-amplified and amplified cases were 5% and 10%, respectively. A weak but significant correlation was observed between topo-II gene amplification level and percentage of positively stained cells (Spearman's ranks correlation coefficient of 0.23, p=0.02), the observed correlation being higher in patients with positive staining for Ki-67. Contrary to HER-2, where gene amplification is almost always correlated with protein overexpression in breast cancer, topo-II gene amplification apparently does not always lead to protein overexpression, at least when the latter is evaluated by IHC. Other factors, specifically the tumor proliferation status, may interfere with the topo-II protein status. Although the great majority of topo-II gene aberrations occur in HER-2 positive tumors, the level of HER-2 amplification does not predict for topo-II amplification.

Related Articles

Journal Cover

November 2004
Volume 25 Issue 5

Print ISSN: 1019-6439
Online ISSN:1791-2423

Sign up for eToc alerts

Recommend to Library

Copy and paste a formatted citation
x
Spandidos Publications style
Durbecq V, Desmed C, Paesmans M, Cardoso F, Di Leo A, Mano M, Rouas G, Leroy J, Sotiriou C, Piccart M, Piccart M, et al: Correlation between topoisomerase-IIα gene amplification and protein expression in HER-2 amplified breast cancer. Int J Oncol 25: 1473-1479, 2004.
APA
Durbecq, V., Desmed, C., Paesmans, M., Cardoso, F., Di Leo, A., Mano, M. ... Larsimont, D. (2004). Correlation between topoisomerase-IIα gene amplification and protein expression in HER-2 amplified breast cancer. International Journal of Oncology, 25, 1473-1479. https://doi.org/10.3892/ijo.25.5.1473
MLA
Durbecq, V., Desmed, C., Paesmans, M., Cardoso, F., Di Leo, A., Mano, M., Rouas, G., Leroy, J., Sotiriou, C., Piccart, M., Larsimont, D."Correlation between topoisomerase-IIα gene amplification and protein expression in HER-2 amplified breast cancer". International Journal of Oncology 25.5 (2004): 1473-1479.
Chicago
Durbecq, V., Desmed, C., Paesmans, M., Cardoso, F., Di Leo, A., Mano, M., Rouas, G., Leroy, J., Sotiriou, C., Piccart, M., Larsimont, D."Correlation between topoisomerase-IIα gene amplification and protein expression in HER-2 amplified breast cancer". International Journal of Oncology 25, no. 5 (2004): 1473-1479. https://doi.org/10.3892/ijo.25.5.1473